Caution- Patients with anaemia may reveal false increase of HbA1c despite normal blood sugar levels

Written By :  Dr. Shravani Dali
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-01-10 14:15 GMT   |   Update On 2024-01-10 14:15 GMT

Haemoglobin A1c (A1c) has become the standard tool for monitoring glycemic control in patients with diabetes since it's clinical use was started in the 1970s. By it's addition as a diagnostic criterion for diabetes in 2010 by American Diabetes Association, the role of the A1c test was broadened. Because of hemoglobin A1c’s integral role in diagnosis and treatment, it is important to...

Login or Register to read the full article

Haemoglobin A1c (A1c) has become the standard tool for monitoring glycemic control in patients with diabetes since it's clinical use was started in the 1970s. By it's addition as a diagnostic criterion for diabetes in 2010 by American Diabetes Association, the role of the A1c test was broadened. Because of hemoglobin A1c’s integral role in diagnosis and treatment, it is important to recognize clinical scenarios and interfering factors that yield false results. Researchers have revealed in an observational pilot study that caution is necessary while interpreting HbA1c as Patients of anemia may show false increase of HbA1c despite normal blood sugar levels. The study has been published in Cureus.

Over the past decades, glycosylated haemoglobin (HbA1c) has been a gold standard for monitoring diabetes control over a long period, relative to blood glucose level (BGL) which measures short-term results. It is speculated that anaemia and factors that induce haemolysis may cause falsely elevated HbA1c leading to 'false positive' interpretations. This study aimed to investigate how anaemia impacts HbA1c. This was a pathology-based observational pilot study using archived data of diabetic subjects monitored with both BGL and HbA1c in regional New South Wales (NSW), Australia. A total of 28,487 cases of blood glucose results were pooled and those with HbA1c and anaemia results were evaluated for correlation with the BGL results. Data collection was limited to de-identified information from the laboratory information system, hence details on the ethnicity and medical history were unavailable. Descriptive frequencies and Pearson correlations were performed. Results: In the pooled data, 53.36% of individuals were females, and 50.54% had BGL ≥5.6 mmol/L. In the pilot dataset, the majority (64.86%) were males, 18.92% with BGL ≤5.6 mmol/L and 67.57% had HbA1c (≥6.5%). In the entire dataset, BGL was moderately and positively correlated with HbA1c (r = 0.6), whereas in the subset of individuals with normo-BGL and anaemia, the correlation was negative (r = -0.2). This pilot investigation observed a pertinent issue, which is a negative correlation between glycaemia and HbA1c in patients with anaemia. HbA1c was falsely increased despite normal blood glucose levels in individuals with anaemia. This advances the speculation that anaemia falsely increases HbA1c. Therefore, caution is necessary while interpreting HbA1c results for patients with anaemia, and new methods for interpretation are required.

Reference:

Bwititi P, Wang L, Butkowski E, Nwose EU. Impact of Anaemia on HbA1c Interpretation Among Normogylcaemic Individuals With Diabetes Mellitus: A Clinical Laboratory Observational Study. Cureus. 2023 Dec 4;15(12):e49901. doi: 10.7759/cureus.49901. PMID: 38174171; PMCID: PMC10763517.


Keywords:

Caution, anemia patients, false increase HbA1c, normal blood sugar levels, Bwititi P, Wang L, Butkowski E, Nwose EU, Cureus, anaemia; diabetes control; haemoglobin a1c; lab interpretation; laboratory test.






Tags:    
Article Source : Cureus

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News